tradingkey.logo

Cigna Group

CI
271.270USD
-1.110-0.41%
Handelsschluss 01/29, 16:00ETKurse um 15 Minuten verzögert
72.32BMarktkapitalisierung
11.91KGV TTM

Cigna Group

271.270
-1.110-0.41%

mehr Informationen über Cigna Group Unternehmen

The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.

Cigna Group Informationen

BörsenkürzelCI
Name des UnternehmensCigna Group
IPO-datumApr 01, 1982
CEOCordani (David M)
Anzahl der mitarbeiter73500
WertpapierartOrdinary Share
GeschäftsjahresendeApr 01
Addresse900 Cottage Grove Road
StadtBLOOMFIELD
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl06002
Telefon18602266000
Websitehttps://www.thecignagroup.com/
BörsenkürzelCI
IPO-datumApr 01, 1982
CEOCordani (David M)

Führungskräfte von Cigna Group

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David M. Cordani, CPA
Mr. David M. Cordani, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
667.15K
-26527.00%
Mr. Brian C. Evanko
Mr. Brian C. Evanko
President, Chief Operating Officer
President, Chief Operating Officer
65.23K
+901.00%
Mr. Eric C. Wiseman
Mr. Eric C. Wiseman
Lead Independent Director
Lead Independent Director
23.16K
+638.00%
Maj. Gen. (Retd.) Elder Granger, M.D.
Maj. Gen. (Retd.) Elder Granger, M.D.
Independent Director
Independent Director
6.11K
+638.00%
Ms. Kathleen M. Mazzarella
Ms. Kathleen M. Mazzarella
Independent Director
Independent Director
6.11K
+638.00%
Ms. Kimberly A. Ross
Ms. Kimberly A. Ross
Independent Director
Independent Director
4.51K
+638.00%
Mr. George Kurian
Mr. George Kurian
Independent Director
Independent Director
3.78K
+638.00%
Ms. Neesha Hathi
Ms. Neesha Hathi
Independent Director
Independent Director
3.37K
+638.00%
Ms. Ann M. Dennison
Ms. Ann M. Dennison
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
2.92K
+2920.00%
Mr. Eric J. Foss
Mr. Eric J. Foss
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David M. Cordani, CPA
Mr. David M. Cordani, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
667.15K
-26527.00%
Mr. Brian C. Evanko
Mr. Brian C. Evanko
President, Chief Operating Officer
President, Chief Operating Officer
65.23K
+901.00%
Mr. Eric C. Wiseman
Mr. Eric C. Wiseman
Lead Independent Director
Lead Independent Director
23.16K
+638.00%
Maj. Gen. (Retd.) Elder Granger, M.D.
Maj. Gen. (Retd.) Elder Granger, M.D.
Independent Director
Independent Director
6.11K
+638.00%
Ms. Kathleen M. Mazzarella
Ms. Kathleen M. Mazzarella
Independent Director
Independent Director
6.11K
+638.00%
Ms. Kimberly A. Ross
Ms. Kimberly A. Ross
Independent Director
Independent Director
4.51K
+638.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Pharmacy revenues
56.05B
80.37%
Premiums
9.08B
13.02%
Fees and other revenues
4.38B
6.28%
Other revenues
233.00M
0.33%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Pharmacy revenues
56.05B
80.37%
Premiums
9.08B
13.02%
Fees and other revenues
4.38B
6.28%
Other revenues
233.00M
0.33%

Aktionärsstatistik

Aktualisiert: Fri, Jan 9
Aktualisiert: Fri, Jan 9
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
9.59%
BlackRock Institutional Trust Company, N.A.
4.73%
State Street Investment Management (US)
4.54%
MFS Investment Management
4.27%
T. Rowe Price Associates, Inc.
4.08%
Andere
72.78%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
9.59%
BlackRock Institutional Trust Company, N.A.
4.73%
State Street Investment Management (US)
4.54%
MFS Investment Management
4.27%
T. Rowe Price Associates, Inc.
4.08%
Andere
72.78%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
52.63%
Investment Advisor/Hedge Fund
28.39%
Research Firm
2.67%
Pension Fund
2.26%
Bank and Trust
1.71%
Hedge Fund
1.58%
Sovereign Wealth Fund
1.39%
Corporation
1.19%
Individual Investor
0.39%
Andere
7.79%

Institutionelle Beteiligung

Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
2907
242.25M
91.45%
+168.59K
2025Q3
2972
242.12M
91.90%
+1.54M
2025Q2
2981
240.55M
93.84%
-5.16M
2025Q1
2971
246.39M
94.63%
-8.92M
2024Q4
2988
249.03M
93.14%
+458.77K
2024Q3
2914
248.98M
92.53%
-1.29M
2024Q2
2894
250.44M
95.06%
-5.89M
2024Q1
2849
256.08M
92.56%
-14.53M
2023Q4
2795
262.30M
92.80%
-573.37K
2023Q3
2699
263.15M
93.94%
-4.31M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
25.62M
9.59%
+27.96K
+0.11%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
12.64M
4.73%
+229.62K
+1.85%
Sep 30, 2025
State Street Investment Management (US)
12.12M
4.54%
-145.49K
-1.19%
Sep 30, 2025
MFS Investment Management
10.55M
3.95%
-863.89K
-7.57%
Sep 30, 2025
T. Rowe Price Associates, Inc.
10.90M
4.08%
+1.00M
+10.12%
Sep 30, 2025
Dodge & Cox
9.31M
3.48%
+354.62K
+3.96%
Sep 30, 2025
Fidelity Management & Research Company LLC
8.27M
3.1%
-538.79K
-6.12%
Sep 30, 2025
Sanders Capital, LLC
7.83M
2.93%
+35.15K
+0.45%
Sep 30, 2025
GQG Partners, LLC
6.79M
2.54%
+1.02M
+17.70%
Sep 30, 2025
Geode Capital Management, L.L.C.
6.00M
2.25%
+39.79K
+0.67%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares U.S. Healthcare Providers ETF
7.92%
VictoryShares Free Cash Flow ETF
3.31%
Invesco Dynamic Buyback Achievers ETF
3.22%
Monarch Dividend Plus Index ETF
2.79%
TrueShares Low Volatility Equity Income ETF
2.58%
Hennessy Sustainable ETF
2.3%
VictoryShares US Multi-Factor Minimum Vol ETF
2.16%
Brandes US Value ETF
1.9%
Bushido Capital US Equity ETF
1.89%
Davis Select US Equity ETF
1.86%
Mehr Anzeigen
iShares U.S. Healthcare Providers ETF
Anteil7.92%
VictoryShares Free Cash Flow ETF
Anteil3.31%
Invesco Dynamic Buyback Achievers ETF
Anteil3.22%
Monarch Dividend Plus Index ETF
Anteil2.79%
TrueShares Low Volatility Equity Income ETF
Anteil2.58%
Hennessy Sustainable ETF
Anteil2.3%
VictoryShares US Multi-Factor Minimum Vol ETF
Anteil2.16%
Brandes US Value ETF
Anteil1.9%
Bushido Capital US Equity ETF
Anteil1.89%
Davis Select US Equity ETF
Anteil1.86%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 5.74B USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Oct 22, 2025
CI.NB Final Cash Dividend of gross USD 1.51 paid on Dec 18, 2025 going ex on Dec 04, 2025 with reinvestment option
Dec 04, 2025
Dec 18, 2025
Dec 04, 2025
Jul 22, 2025
CI.NB Interim Cash Dividend of gross USD 1.51 paid on Sep 18, 2025 going ex on Sep 04, 2025 with reinvestment option
Sep 04, 2025
Sep 18, 2025
Sep 04, 2025
Apr 23, 2025
CI.NB Interim Cash Dividend of gross USD 1.51 paid on Jun 18, 2025 going ex on Jun 03, 2025 with reinvestment option
Jun 03, 2025
Jun 18, 2025
Jun 03, 2025
Jan 30, 2025
CI.NB Interim Cash Dividend of gross USD 1.51 paid on Mar 20, 2025 going ex on Mar 05, 2025 with reinvestment option
Mar 05, 2025
Mar 20, 2025
Mar 05, 2025
Oct 23, 2024
CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024 with reinvestment option
Dec 04, 2024
Dec 19, 2024
Dec 04, 2024
Oct 23, 2024
CI.NB Final Cash Dividend of gross USD 1.4 paid on Dec 19, 2024 going ex on Dec 04, 2024
Dec 04, 2024
Dec 19, 2024
Dec 04, 2024
Jul 24, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Sep 19, 2024 going ex on Sep 04, 2024 with reinvestment option
Sep 04, 2024
Sep 19, 2024
Sep 04, 2024
Apr 24, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Jun 20, 2024 going ex on Jun 04, 2024 with reinvestment option
Jun 04, 2024
Jun 20, 2024
Jun 04, 2024
Feb 02, 2024
CI.NB Interim Cash Dividend of gross USD 1.4 paid on Mar 21, 2024 going ex on Mar 05, 2024 with reinvestment option
Mar 06, 2024
Mar 21, 2024
Mar 05, 2024
Oct 25, 2023
CI.NB Final Cash Dividend of gross USD 1.23 paid on Dec 21, 2023 going ex on Dec 05, 2023
Dec 06, 2023
Dec 21, 2023
Dec 05, 2023
Mehr Anzeigen

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI